Similar rates have been obtained in Kazakhstan, where 25.7% of oropharyngeal cancer cases tested positive for HPV DNA and p16 [31], and in Northeastern Italy, where 20% of oropharyngeal cancer cases tested positive for HPV DNA and HPV RNA [32]. This evidence concerns the gene CDKN2A and oropharynx cancer.